loading
Precedente Chiudi:
$8.50
Aprire:
$8.48
Volume 24 ore:
3.75M
Relative Volume:
3.22
Capitalizzazione di mercato:
$1.06B
Reddito:
$247.00M
Utile/perdita netta:
$-249.00M
Rapporto P/E:
-2.5728
EPS:
-3.09
Flusso di cassa netto:
$-267.00M
1 W Prestazione:
-7.77%
1M Prestazione:
-11.96%
6M Prestazione:
-47.94%
1 anno Prestazione:
-47.59%
Intervallo 1D:
Value
$7.91
$8.64
Intervallo di 1 settimana:
Value
$7.91
$8.87
Portata 52W:
Value
$6.50
$18.98

Arcus Biosciences Inc Stock (RCUS) Company Profile

Name
Nome
Arcus Biosciences Inc
Name
Telefono
(510) 694-6200
Name
Indirizzo
3928 POINT EDEN WAY, HAYWARD, CA
Name
Dipendente
674
Name
Cinguettio
@arcusbio
Name
Prossima data di guadagno
2024-12-06
Name
Ultimi documenti SEC
Name
RCUS's Discussions on Twitter

Confronta RCUS con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
RCUS
Arcus Biosciences Inc
7.95 1.06B 247.00M -249.00M -267.00M -3.09
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
441.30 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
521.00 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
322.83 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
560.14 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
241.20 28.51B 3.81B -644.79M -669.77M -6.24

Arcus Biosciences Inc Stock (RCUS) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-02-26 Aggiornamento H.C. Wainwright Neutral → Buy
2024-10-21 Iniziato H.C. Wainwright Neutral
2024-10-08 Iniziato Wells Fargo Overweight
2022-11-18 Iniziato BofA Securities Neutral
2022-10-11 Iniziato Morgan Stanley Overweight
2021-10-15 Ripresa BTIG Research Buy
2020-11-24 Iniziato Berenberg Buy
2020-11-23 Iniziato Evercore ISI Outperform
2020-04-03 Iniziato Cantor Fitzgerald Overweight
2020-03-04 Iniziato Barclays Overweight
2019-11-12 Iniziato SunTrust Buy
2019-09-27 Iniziato Mizuho Buy
2019-05-24 Ripresa Citigroup Buy
2018-10-09 Iniziato Wedbush Outperform
2018-04-09 Iniziato Citigroup Buy
2018-04-09 Iniziato Goldman Neutral
2018-04-09 Iniziato Leerink Partners Outperform
Mostra tutto

Arcus Biosciences Inc Borsa (RCUS) Ultime notizie

pulisher
Jun 16, 2025

(RCUS) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com

Jun 16, 2025
pulisher
Jun 16, 2025

GAMMA Investing LLC Buys 15,466 Shares of Arcus Biosciences, Inc. (NYSE:RCUS) - Defense World

Jun 16, 2025
pulisher
Jun 14, 2025

Arcus Biosciences’ SWOT analysis: promising cancer therapy stock faces pivotal year - Investing.com

Jun 14, 2025
pulisher
Jun 13, 2025

Arcus Biosciences Sees Unusually High Options Volume (NYSE:RCUS) - Defense World

Jun 13, 2025
pulisher
Jun 12, 2025

Arcus Biosciences Holds Annual Stockholders Meeting - TipRanks

Jun 12, 2025
pulisher
Jun 12, 2025

Arcus Biosciences Inc Inc. (RCUS) Price Performance: A Technical Analysis Perspective - investchronicle.com

Jun 12, 2025
pulisher
Jun 12, 2025

Positive Signs As Multiple Insiders Buy Arcus Biosciences Stock - simplywall.st

Jun 12, 2025
pulisher
Jun 11, 2025

Arcus Biosciences Announces New Employment Inducement Grants | R - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Sells 7,872 Shares of Arcus Biosciences, Inc. (NYSE:RCUS) - Defense World

Jun 11, 2025
pulisher
Jun 11, 2025

Cantor Fitzgerald Comments on RCUS FY2026 Earnings - Defense World

Jun 11, 2025
pulisher
Jun 10, 2025

Arcus Biosciences Announces New Employment Inducement Grants | RCUS Stock News - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

Arcus Biosciences Announces New Employment Inducement Grants - Business Wire

Jun 10, 2025
pulisher
Jun 04, 2025

When the Price of (RCUS) Talks, People Listen - news.stocktradersdaily.com

Jun 04, 2025
pulisher
Jun 04, 2025

Nuveen Asset Management LLC Has $1.96 Million Position in Arcus Biosciences, Inc. (NYSE:RCUS) - Defense World

Jun 04, 2025
pulisher
Jun 03, 2025

Arcus Biosciences, Inc. (NYSE:RCUS) Shares Purchased by Bank of America Corp DE - Defense World

Jun 03, 2025
pulisher
Jun 02, 2025

Arcus Biosciences (RCUS) Unveils Promising Data for Cancer Treat - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

Transcript : Arcus Biosciences, Inc.Special Call - MarketScreener

Jun 02, 2025
pulisher
Jun 02, 2025

Arcus Biosciences Presents Promising Phase 1/1b Trial Data - TipRanks

Jun 02, 2025
pulisher
Jun 02, 2025

Two Sigma Investments LP Purchases 11,027 Shares of Arcus Biosciences, Inc. (NYSE:RCUS) - Defense World

Jun 02, 2025
pulisher
Jun 01, 2025

Arcus Biosciences (RCUS) Unveils Promising Data for Cancer Treatment | RCUS Stock News - GuruFocus

Jun 01, 2025
pulisher
Jun 01, 2025

Arcus Says Initial Data From The Arc-20 Study Of Casdatifan Plus Cabozantinib Showed Nearly Half Of Patients With Metastatic Kidney Cancer Had A Confirmed Response - marketscreener.com

Jun 01, 2025
pulisher
Jun 01, 2025

ProShare Advisors LLC Increases Stake in Arcus Biosciences, Inc. (NYSE:RCUS) - Defense World

Jun 01, 2025
pulisher
Jun 01, 2025

Arcus Biosciences (NYSE:RCUS) Shares Down 8.6% – Here’s What Happened - Defense World

Jun 01, 2025
pulisher
May 29, 2025

Arcus Biosciences, Inc. (NYSE:RCUS) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World

May 29, 2025
pulisher
May 28, 2025

Arcus Biosciences’ SWOT analysis: stock’s potential in cancer therapy market By Investing.com - Investing.com Nigeria

May 28, 2025
pulisher
May 28, 2025

BNP Paribas Financial Markets Purchases 9,016 Shares of Arcus Biosciences, Inc. (NYSE:RCUS) - Defense World

May 28, 2025
pulisher
May 28, 2025

Deutsche Bank AG Boosts Stock Holdings in Arcus Biosciences, Inc. (NYSE:RCUS) - Defense World

May 28, 2025
pulisher
May 28, 2025

Arcus Biosciences’ SWOT analysis: stock’s potential in cancer therapy market - Investing.com

May 28, 2025
pulisher
May 26, 2025

Lazard Asset Management LLC Has $93,000 Stock Holdings in Arcus Biosciences, Inc. (NYSE:RCUS) - Defense World

May 26, 2025
pulisher
May 24, 2025

Barclays Reaffirms Their Buy Rating on Arcus Biosciences (RCUS) - The Globe and Mail

May 24, 2025
pulisher
May 23, 2025

Discovery of AB801, a Potent and Selective Inhibitor of AXL Receptor Tyrosine Kinase for Use in Cancer Therapy - ACS Publications

May 23, 2025
pulisher
May 22, 2025

Recent Investment Analysts’ Ratings Changes for Arcus Biosciences (RCUS) - Defense World

May 22, 2025
pulisher
May 19, 2025

Arcus Biosciences, Inc. (NYSE:RCUS) Shares Bought by Northern Trust Corp - Defense World

May 19, 2025
pulisher
May 19, 2025

Arcus Biosciences Stock May Be The Next To Fail (NYSE:RCUS) - Seeking Alpha

May 19, 2025
pulisher
May 16, 2025

Arcus Biosciences, Inc. (NYSE:RCUS) Analysts Just Slashed This Year's Revenue Estimates By 17% - simplywall.st

May 16, 2025
pulisher
May 14, 2025

Trading (RCUS) With Integrated Risk Controls - news.stocktradersdaily.com

May 14, 2025
pulisher
May 14, 2025

Price T Rowe Associates Inc. MD Sells 6,265 Shares of Arcus Biosciences, Inc. (NYSE:RCUS) - Defense World

May 14, 2025
pulisher
May 12, 2025

Morgan Stanley Cuts Arcus Biosciences (NYSE:RCUS) Price Target to $22.00 - Defense World

May 12, 2025
pulisher
May 11, 2025

First Trust Advisors LP Has $264,000 Stock Holdings in Arcus Biosciences, Inc. (NYSE:RCUS) - Defense World

May 11, 2025
pulisher
May 11, 2025

Cantor Fitzgerald Has Weak Forecast for RCUS FY2025 Earnings - Defense World

May 11, 2025
pulisher
May 10, 2025

HC Wainwright Predicts Weaker Earnings for Arcus Biosciences - Defense World

May 10, 2025
pulisher
May 10, 2025

Arcus Biosciences (RCUS): Morgan Stanley Lowers Price Target | R - GuruFocus

May 10, 2025
pulisher
May 10, 2025

Wedbush Decreases Earnings Estimates for Arcus Biosciences - Defense World

May 10, 2025
pulisher
May 09, 2025

Raymond James Financial Inc. Makes New Investment in Arcus Biosciences, Inc. (NYSE:RCUS) - Defense World

May 09, 2025
pulisher
May 09, 2025

Morgan Stanley Lowers Price Target on Arcus Biosciences to $22 From $24, Keeps Overweight Rating - marketscreener.com

May 09, 2025
pulisher
May 09, 2025

Arcus Biosciences, Inc. (RCUS) Reports Q1 Loss, Lags Revenue Estimates - MSN

May 09, 2025
pulisher
May 08, 2025

Goldman Sachs Adjusts Price Target for Arcus Biosciences (RCUS) - GuruFocus

May 08, 2025
pulisher
May 08, 2025

Goldman Sachs Adjusts Price Target for Arcus Biosciences (RCUS) | RCUS Stock News - GuruFocus

May 08, 2025
pulisher
May 08, 2025

Wells Fargo Adjusts Price Target for Arcus Biosciences (RCUS) to $26 | RCUS Stock News - GuruFocus

May 08, 2025
pulisher
May 08, 2025

Arcus Biosciences First Quarter 2025 Earnings: Misses Expectations - Yahoo Finance

May 08, 2025
pulisher
May 08, 2025

Arcus Biosciences (RCUS) Receives Adjusted Price Target from Wel - GuruFocus

May 08, 2025

Arcus Biosciences Inc Azioni (RCUS) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Arcus Biosciences Inc Azioni (RCUS) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
ROSEN TERRY J
Chief Executive Officer
Feb 27 '25
Buy
10.18
19,800
201,465
2,554,160
GILEAD SCIENCES, INC.
10% Owner
Feb 18 '25
Buy
11.00
1,363,636
14,999,996
31,424,760
Goeltz II Robert C.
Chief Financial Officer
Dec 31 '24
Sale
15.00
3,594
53,910
60,138
$20.50
price down icon 1.11%
$35.87
price up icon 1.70%
$20.60
price down icon 3.38%
$99.49
price down icon 2.21%
$106.72
price up icon 0.55%
biotechnology ONC
$241.20
price down icon 5.22%
Capitalizzazione:     |  Volume (24 ore):